Docstoc

2012 Aarkstore.com | Adenocarcinoma – Pipeline Review, H2 2012

Document Sample
2012 Aarkstore.com | Adenocarcinoma – Pipeline Review, H2 2012 Powered By Docstoc
					   Adenocarcinoma – Pipeline Review, H2 2012


Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Adenocarcinoma – Pipeline Review, H2 2012



You can also request for sample page of above mention reports on
sample@aarkstore.com


Summary

Global Markets Direct’s, Adenocarcinoma - Pipeline Review, H2 2012, provides an
overview of the Adenocarcinoma therapeutic pipeline. This report provides
information on the therapeutic development for Adenocarcinoma, complete with
latest updates, and special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for Adenocarcinoma.
Adenocarcinoma - Pipeline Review, H2 2012 is built using data and information
sourced from Global Markets Direct’s proprietary databases, Company/University
websites, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together by
Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Adenocarcinoma.
- A review of the Adenocarcinoma products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
   Adenocarcinoma – Pipeline Review, H2 2012
Table of contents:

List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Adenocarcinoma Overview 9
Therapeutics Development 10
An Overview of Pipeline Products for Adenocarcinoma 10
Adenocarcinoma Therapeutics under Development by Companies 12
Adenocarcinoma Therapeutics under Investigation by Universities/Institutes 15
Late Stage Products 19
Comparative Analysis 19
Mid Clinical Stage Products 20
Comparative Analysis 20
Early Clinical Stage Products 21
Comparative Analysis 21
Discovery and Pre-Clinical Stage Products 22
Comparative Analysis 22
Adenocarcinoma Therapeutics – Products under Development by Companies 23
Adenocarcinoma Therapeutics – Products under Investigation by
Universities/Institutes 25
Companies Involved in Adenocarcinoma Therapeutics Development 30
F. Hoffmann-La Roche Ltd. 30
Amgen Inc. 31
Sanofi-Aventis 32
Eli Lilly and Company 33
Gilead Sciences, Inc. 34
BioLineRx, Ltd. 35
Novartis AG 36
Astellas Pharma Inc. 37
Pfizer Inc. 38
Aduro BioTech 39
Celgene Corporation 40
Merck KGaA 41
Novartis Pharmaceuticals Corporation 42
Alchemia Limited 43
   Adenocarcinoma – Pipeline Review, H2 2012
Celldex Therapeutics, Inc. 44
Lorus Therapeutics Inc 45
AVAX Technologies, Inc. 46
Oncolytics Biotech Inc. 47
Threshold Pharmaceuticals, Inc. 48
GANYMED Pharmaceuticals AG 49
Merrimack Pharmaceuticals, Inc. 50
Axcentua Pharmaceuticals AB 51
BioCancell Therapeutics, Inc. 52
Kinex Pharmaceuticals, LLC 53
Adenocarcinoma – Therapeutics Assessment 54
Assessment by Monotherapy Products 54
Assessment by Combination Products 55



List of Figures

List of Tables are also include.



For more related Reports Plz follow The link:

Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1




Pulmonary Hypertension – Pipeline Review, H2 2012

Leukocyte Disorders (White Blood Cell Disorders) – Pipeline Review, H2 2012

Brain Metastasis – Pipeline Review, H2 2012

Swine Influenza – Pipeline Review, H2 2012
   Adenocarcinoma – Pipeline Review, H2 2012
Adenocarcinoma – Pipeline Review, H2 2012

Fungal Infections – Pipeline Review, H2 2012

Mycobacterium Infections – Pipeline Review, H2 2012

Brain Cancer – Pipeline Review, H2 2012

Metastatic Colorectal Cancer – Pipeline Review, H2 2012

Orthomyxoviridae Infections – Pipeline Review, H2 2012




Search More Reports Related to This Category :


Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:4
posted:9/13/2012
language:
pages:4